IRIS UniCatt

Cammarota, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.796
NA - Nord America 11.102
AS - Asia 9.283
SA - Sud America 2.190
AF - Africa 222
Continente sconosciuto - Info sul continente non disponibili 34
OC - Oceania 33
Totale 35.660
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.747
DE - Germania 5.346
SG - Singapore 4.302
CN - Cina 2.671
BR - Brasile 1.815
IT - Italia 1.672
SE - Svezia 1.573
UA - Ucraina 837
FR - Francia 700
GB - Regno Unito 667
IE - Irlanda 473
VN - Vietnam 432
PL - Polonia 392
IN - India 360
ID - Indonesia 342
FI - Finlandia 340
RU - Federazione Russa 259
TR - Turchia 195
CA - Canada 164
HK - Hong Kong 155
AR - Argentina 148
JP - Giappone 126
NL - Olanda 110
MX - Messico 109
BD - Bangladesh 108
IQ - Iraq 94
KR - Corea 89
BE - Belgio 85
ES - Italia 85
EC - Ecuador 54
ZA - Sudafrica 53
PK - Pakistan 51
AT - Austria 47
VE - Venezuela 43
CO - Colombia 41
CH - Svizzera 40
CZ - Repubblica Ceca 33
IR - Iran 33
SA - Arabia Saudita 32
UZ - Uzbekistan 32
IL - Israele 30
MA - Marocco 30
AE - Emirati Arabi Uniti 29
JO - Giordania 29
EU - Europa 27
KE - Kenya 27
AU - Australia 26
CL - Cile 26
LT - Lituania 25
TN - Tunisia 25
PY - Paraguay 22
KZ - Kazakistan 18
AZ - Azerbaigian 17
EG - Egitto 17
DZ - Algeria 15
RO - Romania 15
CI - Costa d'Avorio 14
PA - Panama 14
PT - Portogallo 14
JM - Giamaica 13
UY - Uruguay 13
BH - Bahrain 12
BO - Bolivia 12
NP - Nepal 12
PE - Perù 12
TW - Taiwan 12
CR - Costa Rica 11
LK - Sri Lanka 11
HR - Croazia 10
OM - Oman 10
DO - Repubblica Dominicana 9
GE - Georgia 9
HU - Ungheria 9
LB - Libano 9
PH - Filippine 9
RS - Serbia 9
AL - Albania 8
GR - Grecia 7
TT - Trinidad e Tobago 7
BY - Bielorussia 6
ET - Etiopia 6
HN - Honduras 6
NG - Nigeria 6
SK - Slovacchia (Repubblica Slovacca) 6
SN - Senegal 6
SY - Repubblica araba siriana 6
BG - Bulgaria 5
GT - Guatemala 5
KG - Kirghizistan 5
KW - Kuwait 5
MY - Malesia 5
NZ - Nuova Zelanda 5
BZ - Belize 4
CY - Cipro 4
GH - Ghana 4
LA - Repubblica Popolare Democratica del Laos 4
NO - Norvegia 4
PS - Palestinian Territory 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
Totale 35.581
Salva come PNG Salva come JPEG
Città #
Singapore 1.837
Chandler 1.774
Ashburn 1.118
Jacksonville 485
Dublin 465
Beijing 458
San Mateo 383
Nürnberg 378
Ann Arbor 359
Hefei 327
Jakarta 314
Nanjing 300
Los Angeles 277
New York 276
Warsaw 275
Rome 274
Woodbridge 231
Boston 226
Wilmington 225
Milan 223
Munich 215
Cattolica 188
Dearborn 167
Marseille 166
Princeton 152
Ho Chi Minh City 151
São Paulo 145
Houston 143
Frankfurt am Main 140
Hong Kong 139
Moscow 137
Fairfield 136
Izmir 134
Seattle 133
Redwood City 124
Chicago 112
Nanchang 112
Dallas 109
Hanoi 103
Buffalo 101
Kent 89
Lawrence 89
Seoul 84
Tokyo 79
Helsinki 78
Boardman 77
Brussels 77
Kraków 75
Turku 74
Shanghai 73
Shenyang 73
Hangzhou 71
London 71
Fuzhou 68
The Dalles 66
Rio de Janeiro 63
Lancaster 59
Redmond 59
Bremen 57
Hebei 57
Santa Clara 57
Verona 55
Brooklyn 54
Mountain View 54
Nuremberg 54
Guangzhou 52
Leawood 52
Pune 49
Zhengzhou 49
Belo Horizonte 48
Kunming 47
Tianjin 47
Denver 44
Stockholm 44
University Park 44
Las Vegas 43
Phoenix 43
Baghdad 42
Changsha 42
Cambridge 40
Toronto 40
Düsseldorf 38
Norwalk 37
San Francisco 37
Fremont 36
North Bergen 35
Atlanta 33
Augusta 33
Jiaxing 33
Montreal 32
Johannesburg 31
Amman 29
Amsterdam 29
Dhaka 29
Falls Church 29
Curitiba 28
Manchester 28
Poplar 28
Chennai 27
Orem 27
Totale 16.050
Salva come PNG Salva come JPEG
Nome #
-Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth 490
A case-control study comparing methylene blue directed biopsies and random biopsies for detecting pre-cancerous lesions in the follow-up of gastric cancer patients 412
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns 408
Small intestinal bacterial overgrowth recurrence after antibiotic therapy 406
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 339
gc) Water-immersion technique during standard upper endoscopy may be useful to drive the biopsy sampling of duodenal mucosa in children with celiac disease. 295
Gut microbiota in anxiety and depression: Pathogenesis and therapeutics 264
ag)Association between hypothyroidism and small intestinal bacterial overgrowth 248
A) Lack of endoscopic visualization of intestinal villi with the "immersion technique" in overt atrophic celiac disease 242
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 238
A highly accurate method for monitoring histological recovery in patients with celiac disease on a gluten-free diet using an endoscopic approach that avoids the need for biopsy: a double-center study 234
High accuracy and cost-effectiveness of a biopsy-avoiding endoscopic approach in diagnosing coeliac disease. 234
Wheat desensitization treatment in patients with gluten sensitivity 234
gc) Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. 228
gc) Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. 223
-High prevalence of celiac disease in patients with lactose intolerance 213
Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study 210
The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy 207
gc) Patchy left-sided colitis: primary eosinophilic colitis or paraneoplastic syndrome ? 203
The role of diet on gut microbiota composition 201
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 200
A) Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial. 199
T-bet and pSTAT1 expression in peripheral blood mononuclear cells from coeliac disease patients: new markers of disease activity 197
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 194
A) Reliability of the "immersion technique" during routine upper endoscopy for detection of abnormalities of duodenal villi in patients with dyspepsia. 193
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study. 193
Decrease in Surgery for Clostridium difficile Infection After Starting a Program to Transplant Fecal Microbiota 193
-Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection. 191
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 190
GC)Optimal band imaging system: a new tool for enhancing the duodenal villous pattern in celiac disease. 187
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 186
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 185
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 181
Diagnostic and therapeutic impact of double-balloon enteroscopy (DBE) in a series of 100 patients with suspected small bowel diseases 176
Fecal microbiota transplantation: Past, present and future perspectives 176
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 176
. Adverse reactions to food: allergies and intolerances. 175
Celiac disease: what's new about it? 171
Dramatic improvement of parkinsonian symptoms after gluten-free diet introduction in a patient with silent celiac disease 171
Can chronic gastritis cause an increase in fecal calprotectin concentrations? 168
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 168
Helicobacter pylori eradication rate and glycemic control in young patients with type 1 diabetes 167
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 165
Nickel free-diet enhances the Helicobacter pylori eradication rate: a pilot study 165
(gc)Association of laryngeal cancer with previous gastric resection. 163
Increased expression of T-bet in circulating B cells from a patient with multiple sclerosis and celiac disease 162
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. 161
Can chronic gastritis cause increase of fecal calprotectin concentrations? 160
Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. 160
-Double-balloon enteroscopy for diagnosis of a Meckel's diverticulum in a patient with GI bleeding of obscure origin 158
Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication 157
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 156
A) Association of laryngeal cancer with previous gastric resection 155
Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns 155
Combined atherogenic effects of celiac disease and type 1 diabetes mellitus 154
A) High levels of dual resistance to clarithromycin and metronidazole and in vitro activity of levofloxacin against Helicobacter pylori isolates from patients after failure of therapy. 154
Image-Enhanced Endoscopy with I-scan Technology for the Evaluation of Duodenal Villous Patterns. 154
-Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth 153
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 153
[Helicobacter pylori infection: from gastric to systemic disease] 151
Relationship between gastric localization of hepatitis C virus and mucosa-associated lymphoid tissue in Helicobacter pylori infection 149
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 148
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 147
ag) Fecal calprotectin in first-degree relatives of patients with ulcerative colitis. 146
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response 145
Key determinants of success in fecal microbiota transplantation: From microbiome to clinic 144
A) Gastric surgery as a long-term risk factor for malignant lesions of the larynx. 144
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. 143
Classification of malabsorption syndromes. 142
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. 142
Post-cholecystectomy alkaline reactive gastritis: a randomized trial comparing sucralfate versus rabeprazole or no treatment 141
Fecal calprotectin in first-degree relatives of patients with ulcerative colitis 141
gc) Tired legs a gut diagnosis 140
Microscopic colitis 140
Faecal calprotectin concentrations in untreated coeliac patients 140
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 140
Gut microbiome, big data and machine learning to promote precision medicine for cancer 140
Levofloxacin based regimens for the eradication of Helicobacter pylori 139
Prophylactic aspirin therapy does not increase faecal calprotectin concentrations. 139
gastroesophageal reflux disease: facts and uncertaines 139
Link between Helicobacter pylori infection and iron-deficiency anaemia in patients with coeliac disease 139
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 139
Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics 138
. Quick test: a new test for the diagnosis of duodenal hypolactasia. 138
Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study 138
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth. 138
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 137
-Accuracy of laryngeal examination during upper gastrointestinal endoscopy for premalignancy screening: prospective study in patients with and without reflux symptoms. 136
Gluten-related Recurrent Peripheral Facial Palsy 135
(gc) Direct visualization of intestinal villi by high-resolution magnifying upper endoscopy: a validation study 135
Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy 135
Celiac disease and chronic urticaria resolution: a case report. 135
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders 134
Increased CD4(+)CD25(+)Foxp3(+) T Cells in Peripheral Blood of Celiac Disease Patients: Correlation with Dietary Treatment. 133
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 133
Moderately Severe Acute Pancreatitis Associated With Riluzole 133
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 132
Role of yeasts in healthy and impaired gut microbiota: the gut mycome 131
Reflux symptoms in wind instrument players. 130
Therapeutic modulation of gut microbiota: current clinical applications and future perspectives. 130
Totale 17.950
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.388
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 146.388
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.241 0 0 0 0 0 170 231 54 233 91 395 67
2021/20222.093 117 185 57 129 130 89 39 337 97 95 388 430
2022/20234.882 628 658 365 732 320 599 247 386 596 94 159 98
2023/20242.645 133 704 90 173 119 318 175 95 70 156 322 290
2024/20255.946 148 198 470 167 456 189 165 326 831 588 1.257 1.151
2025/20268.742 2.423 534 951 1.672 2.551 611 0 0 0 0 0 0
Totale 36.043